Dr. Lewis R. Roberts is the Peter and Frances Georgeson Professor in Gastroenterology Cancer Research and Consultant in Gastroenterology and Hepatology at the Mayo Clinic, where he is Co-Chair of the Hepatobiliary Cancer Disease Group of Mayo Clinic Cancer Center, Co-Principal Investigator of the Mayo Specialized Program of Research Excellence (SPORE) in Hepatobiliary Cancers, Associate Director of Pre-Doctoral Programs in the Center for Clinical and Translational Sciences, and Director for Research at Mayo Clinic Alix School of Medicine. Dr. Roberts earned his medical degree from the University of Ghana Medical School, a PhD in Physiology and Biophysics from The University of Iowa, and completed postgraduate training in Internal Medicine, Gastroenterology and Hepatology, and Cancer Genetics at Mayo Clinic. Dr. Roberts practice is focused on liver and biliary cancers and gastrointestinal endoscopy. His research focuses on molecular mechanisms of liver and biliary carcinogenesis; biomarkers for diagnosis of liver, bile duct and pancreas cancers; and prevention, diagnosis and treatment of hepatitis and liver cancer in Africa as well as in immigrant African communities in the USA. He has been funded by the National Institutes of Health, Robert Wood Johnson Foundation, American Gastroenterological Association Foundation, American College of Gastroenterology, The Cholangiocarcinoma Foundation and PSC Partners Seeking a Cure. He has authored over 380 articles, book chapters and letters, and the book “Evaluation and Management of Liver Masses”. Dr. Roberts is currently Deputy Editor of Hepatology and is on the Editorial Board of Liver Cancer. He serves as President of Africa Partners Medical, a non-profit organization focused on improving healthcare delivery in Africa through medical education, practical skills training, provision of medical equipment and supplies, and health advocacy, as President of the West Africa Institute for Liver and Digestive Diseases Foundation, and as a member of the Advisory Council for The Hepatitis Fund.
